Remove 2017 Remove COVID-19 Remove Public Health Remove World Health
article thumbnail

Stressed Out By COVID and Civil Unrest – the APA’s Stress in America Survey, Part 2

Health Populi

say the future of America is a significant source of stress, as discussed in Stress in the Time of COVID-19, Volume Two , a report covering a poll of U.S. residents through the lens of health consumers and, especially this year and in this study, health citizens. adults age 19 and over between May 21 and June 3, 2020.

article thumbnail

How the Medical Industry Can Help Combat the Current Coronavirus Crisis

Exeed Regulatory Compliance

A novel coronavirus, now called SARS-CoV-19, was first detected in the Hubei province of China in early December 2019. Travel is being restricted, large scale public events are likely to be cancelled, and schools and businesses may be closed to contain the spread of the virus. There is now an FDA policy released on 29 Feb.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. A concerted and collaborative effort is essential to address this threat to global health, economies, and security effectively.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

Experience with large-scale events such as Hurricane Maria and the COVID-19 pandemic, and more recent geopolitical events, have cast a wider lens on global supply chain and distribution vulnerabilities. The model provides expanded guidance that reflects new insight and best practices that have emerged in the past several years.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

19 Medical Rehabilitation Equipment. The EC presented a first draft for public comment to the revision of Annex 1 in 2017. More than 6,000 comments led, quite unusually, to a second draft for renewed public comment in 2020. CMDE Announcement No. 04 Orthopedic Surgical Instruments. 09 Physiotherapy Equipment.

FDA 40
article thumbnail

The 2022 Health Populi TrendCast for Consumers and Health Citizens

Jane Sarashon

This feels especially apt right “now” as we enter 2022, Year 3 of the COVID-19 pandemic, with people mentally stressed, anxious, and shrugging off the Omicron variant – while taking on more DIY life-flows, self-care and desire for (more) control. That well-used and timely observation is known as Amara’s Law.